Methotrexate Recruiting Phase 2 Trials for Mesothelioma / Malignant Pleural Mesothelioma (MPM) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02611037Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma